Literature DB >> 8263913

Conformational variability of chicken cystatin. Comparison of structures determined by X-ray diffraction and NMR spectroscopy.

R A Engh1, T Dieckmann, W Bode, E A Auerswald, V Turk, R Huber, H Oschkinat.   

Abstract

The structural model derived from X-ray crystallography for unphosphorylated wild-type chicken cystatin is compared with two chicken cystatin structures derived from NMR spectroscopy: the phosphorylated wild-type and the genetically engineered variant AEF-SIM-M29I-M89L. The comparison shows the same overall fold, but also significant differences in structurally variable segments of the polypeptide chain. The largest such segment, comprising residues 71 to 89, is a region characteristic of the family 2 cystatin inhibitors which contains a disulphide bridge (71-81) and the phosphorylation site (Ser80) discussed in the accompanying article. In the crystal structure, the segment 71 to 76 is found as a flexible loop, 77 to 85 as an alpha-helical segment, and 86 to 89 is completely undefined. The solution NMR structures on the other hand are disordered in the initial segment 72 to 80, have an extended conformation at 81 to 83 in contact with the beta-sheet, and clearly show a beta-turn at residues 87 to 90. The segment comprising residues 53 to 57, with smaller variability, is of particular interest as the hairpin loop conserved throughout the cystatin superfamily which binds to the cysteine proteinase. In most of the solution NMR structures, this segment adopts a conformation more like that of stefin B, a family 1 cystatin inhibitor, as was observed in the crystal structure of its inhibitory complex with papain. The differences between the structures are rationalized by an examination of the crystal contacts generated by hypothetical crystal packing of the NMR structures. Additionally, the X-ray refinement shows evidence of conformational disorder in the crystal. Joint refinement with NOE restraints and reflection data does not produce a structure to satisfy the restraints of both methods.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263913     DOI: 10.1006/jmbi.1993.1659

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  The major transition state in folding need not involve the immobilization of side chains.

Authors:  R A Staniforth; J L Dean; Q Zhong; E Zerovnik; A R Clarke; J P Waltho
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily.

Authors:  R A Staniforth; S Giannini; L D Higgins; M J Conroy; A M Hounslow; R Jerala; C J Craven; J P Waltho
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

3.  Comparing NMR and X-ray protein structure: Lindemann-like parameters and NMR disorder.

Authors:  Eshel Faraggi; A Keith Dunker; Joel L Sussman; Andrzej Kloczkowski
Journal:  J Biomol Struct Dyn       Date:  2017-08-08

4.  Interaction between oligomers of stefin B and amyloid-beta in vitro and in cells.

Authors:  Katja Skerget; Ajda Taler-Vercic; Andrej Bavdek; Vesna Hodnik; Slavko Ceru; Magda Tusek-Znidaric; Tiina Kumm; Didier Pitsi; Marusa Pompe-Novak; Peep Palumaa; Salvador Soriano; Natasa Kopitar-Jerala; Vito Turk; Gregor Anderluh; Eva Zerovnik
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

5.  Insights into equilibrium dynamics of proteins from comparison of NMR and X-ray data with computational predictions.

Authors:  Lee-Wei Yang; Eran Eyal; Chakra Chennubhotla; JunGoo Jee; Angela M Gronenborn; Ivet Bahar
Journal:  Structure       Date:  2007-06       Impact factor: 5.006

6.  Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.

Authors:  G Lalmanach; C Serveau; M Brillard-Bourdet; J R Chagas; R Mayer; L Juliano; F Gauthier
Journal:  J Protein Chem       Date:  1995-11

7.  Crystal structure of tarocystatin-papain complex: implications for the inhibition property of group-2 phytocystatins.

Authors:  Ming-Hung Chu; Kai-Lun Liu; Hsin-Yi Wu; Kai-Wun Yeh; Yi-Sheng Cheng
Journal:  Planta       Date:  2011-03-18       Impact factor: 4.116

8.  Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom.

Authors:  M Brillard-Bourdet; V Nguyên; M Ferrer-di Martino; F Gauthier; T Moreau
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

9.  Structural characterization of V57D and V57P mutants of human cystatin C, an amyloidogenic protein.

Authors:  Marta Orlikowska; Aneta Szymańska; Dominika Borek; Zbyszek Otwinowski; Piotr Skowron; Elżbieta Jankowska
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-03-14

10.  Phylogenomic analysis of the cystatin superfamily in eukaryotes and prokaryotes.

Authors:  Dusan Kordis; Vito Turk
Journal:  BMC Evol Biol       Date:  2009-11-18       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.